Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
about
The Philadelphia chromosome in leukemogenesisTransformation of Canine Lymphoma/Leukemia to More Aggressive Diseases: Anecdotes or Reality?Light microscopic detection of BCR-ABL transcripts after in-cell RT-PCR: fusion gene expression might correlate with clinical evolution of chronic myeloid leukemia.BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle.bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.Chronic myelogenous leukaemia.Chronic myelogenous leukemia: laboratory diagnosis and monitoring.Acute promyelocytic leukemia: where does it stem from?Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia.DNA Repair--A Double-Edged Sword in the Genomic Stability of Cancer Cells--The Case of Chronic Myeloid Leukemia.Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia.Applying the discovery of the Philadelphia chromosome.Development of acute leukaemia after idiopathic myelofibrosis.Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentationChronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues.Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors.BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.Natural course and biology of CML.Minimal Residual Disease Eradication in CML: Does It Really Matter?Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part II: Chronic Granulocytic Leukemia.Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.Autocrine secretion of osteopontin results in degradation of I kappa B in Bcr-Abl-expressing cells.Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach.Prognostic significance of the surface antigens expressed by leukemic cells.Treatment of chronic myelogenous leukemia in blast crisis and in accelerated phase with high- or intermediate-dose cytosine arabinoside and amsacrine.Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance.An Atypical Initial Presentation of Chronic Myeloid Leukemia with Central Nervous System and Lymph Node Blast CrisesSwollen lymph nodes may not be clinical manifestations of chronic myeloid leukemia: case report and revision of literature.Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia.Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report.Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsLeukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha.STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia.Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia.High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis.Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group.
P2860
Q26745531-625A53E6-6399-42B6-BDE9-899B2BB2DC67Q26776071-E3F897C2-18EC-4E63-AC78-D96D57ACA541Q30839100-9C56D69D-339B-432B-86BD-1AD7D1AAAC79Q33368284-D7F24A95-9A47-4ECA-9888-E6CBBBD5B15DQ33919315-6A54BCC1-C0DF-4DB6-B80B-AE2F10CC17E8Q34135279-37A4C8E1-F189-4792-8E80-7CBE9AD2A3A7Q34364223-144B822A-7D5A-48A9-BC6D-1AE725C7C1F9Q35635316-50AA8CF2-23FF-4347-A811-819397315C7AQ35876347-8EBFF84E-83A5-4A40-B18E-FB87E50C807EQ36324767-CC843355-27DF-4750-8A4D-E2957D88FD66Q36362047-69BB3D2A-7F1D-43E6-B9C4-08B1CCD79B71Q36900109-CFB5EAB4-1B84-4054-B980-5B743461E66EQ37111638-9F99B862-077F-4FA5-A386-288A4B273615Q37170788-C55D52F4-E9EF-4C15-9EF3-D09EE6A5F3E7Q37360559-374ADE2C-2DFC-4606-83AC-D0B25155EF96Q37362966-D54E03BB-F594-4641-ADC1-13A5C717E34CQ37566249-A66D6903-AB0A-4CEF-A005-9A789F777A6BQ37587536-6935423F-368F-4034-A9C0-24E88A7065C5Q37830694-60536F43-AB9E-41EC-B99E-74CBC4A977BBQ37836928-4EEA2EE7-E657-47D5-B57D-71DA51290BAFQ37869368-7AE16FC0-1166-4D30-8D0E-A8581D9E5F9FQ38392667-18167092-38E3-4476-AFBD-8465ED42A656Q38602633-32616ECD-A199-493E-ACAB-253391DC23DCQ38894184-9164A1F7-7EC0-4EAF-9F22-EEBD5F0313DCQ39429836-8630A223-1636-4D9C-804F-369289C4AE6AQ40455729-9663EECA-AA0B-496C-905C-221897142F1FQ40680486-F4014397-9456-469B-8F0F-0DDB467A6165Q40696870-0DBDAA4D-9E1F-4BE6-BC63-4CBEBA594642Q40771434-EAAC999E-D8AC-46C5-A2C0-FA597FA80683Q40931241-DBC0A9DF-B138-4D40-A264-234BACDAB1A3Q41236236-D31D5677-E14F-42D6-8543-53D05FF72D26Q41386039-A5DD93D5-9EC3-43CA-9BC2-E922F509E0DBQ41673629-53A60ACF-F0A0-438C-9DD5-0C708F6425D6Q41870083-EC46E2D2-AA50-4E24-B729-978EB0FD2579Q41899882-B29A7F34-D39C-4DD1-A58A-46A961874A7FQ42119907-B960B6D0-30B6-4147-B6C7-9489F372E13FQ42153537-FEFFDE93-623F-4A48-A134-65AE6C85494EQ43600764-258C61AC-33D0-4C80-BC98-26CD24A871F9Q43601293-9AB58411-28EC-4456-BEBA-13B83B1F2AB9Q44117294-233E3203-5297-44D7-9FA1-E37743137F31
P2860
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
@ast
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
@en
type
label
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
@ast
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
@en
prefLabel
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
@ast
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
@en
P2093
P1476
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
@en
P2093
Freireich EJ
Kantarjian HM
Keating MJ
McCredie KB
Walters RS
P304
P356
10.1016/0002-9343(87)90754-6
P407
P577
1987-09-01T00:00:00Z